T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.79B |
| 2 |
PayPal
PYPL
|
+$1.64B |
| 3 |
Alibaba
BABA
|
+$1.46B |
| 4 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$1.11B |
| 5 |
Johnson Controls International
JCI
|
+$1.09B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TotalEnergies
TTE
|
+$8.15B |
| 2 |
TYC
TYCO INTL PLC COM SHS (IRL)
TYC
|
+$1.77B |
| 3 |
Bristol-Myers Squibb
BMY
|
+$1.74B |
| 4 |
Danaher
DHR
|
+$1.54B |
| 5 |
GE Aerospace
GE
|
+$1.26B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.56% |
| 2 | Consumer Discretionary | 15.28% |
| 3 | Financials | 14.93% |
| 4 | Technology | 13.43% |
| 5 | Communication Services | 9.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Prologis
PLD
$134B
| $513M | 0.1% |
9,588,197
-170,484
| -2% | -$9M |
|
227
Idexx Laboratories
IDXX
$45B
| $512M | 0.1% |
4,546,191
+14,294
| +0.3% | +$1.51M |
|
228
Coca-Cola
KO
$373B
| $512M | 0.1% |
12,103,576
+111,470
| +0.9% | +$4.88M |
|
229
KeyCorp
KEY
$24.5B
| $511M | 0.1% |
41,961,531
+23,213,619
| +124% | +$278M |
|
230
Aramark
ARMK
$15.9B
| $505M | 0.1% |
18,403,435
+7,242,843
| +65% | +$191M |
|
|
SRCL
231
DELISTED
Stericycle Inc
SRCL
| $504M | 0.1% |
6,294,533
+6,096,128
| +3,073% | +$551M |
|
232
Amgen
AMGN
$225B
| $497M | 0.1% |
2,978,125
+256,691
| +9% | +$43.4M |
|
|
PFPT
233
DELISTED
Proofpoint, Inc.
PFPT
| $497M | 0.1% |
6,636,492
+359,578
| +6% | +$26.5M |
|
|
LVNTA
234
DELISTED
Liberty Interactive Corporation Series A Liberty Ventures
LVNTA
| $493M | 0.1% |
12,372,566
+1,080,729
| +10% | +$42.1M |
|
235
Old Dominion Freight Line
ODFL
$44.1B
| $488M | 0.1% |
21,319,728
+808,446
| +4% | +$18.3M |
|
236
Macerich
MAC
$6.99B
| $487M | 0.1% |
6,018,721
-974,364
| -14% | -$82.3M |
|
237
Western Digital
WDC
$157B
| $486M | 0.1% |
10,999,523
-5,578,049
| -34% | -$210M |
|
238
Emerson Electric
EMR
$91.4B
| $484M | 0.1% |
8,885,070
+1,223,304
| +16% | +$65.6M |
|
239
Atlassian
TEAM
$39.4B
| $483M | 0.1% |
16,127,232
+1,783,726
| +12% | +$52.2M |
|
240
Regeneron Pharmaceuticals
REGN
$82.2B
| $481M | 0.1% |
1,197,464
-618,529
| -34% | -$248M |
|
241
Revvity
RVTY
$13.2B
| $480M | 0.1% |
8,547,518
+136,105
| +2% | +$7.43M |
|
242
Neurocrine Biosciences
NBIX
$15.9B
| $474M | 0.1% |
9,364,314
+169,460
| +2% | +$8.44M |
|
243
TC Energy
TRP
$66.3B
| $473M | 0.1% |
9,955,287
+4,180,307
| +72% | +$195M |
|
244
JB Hunt Transport Services
JBHT
$25.9B
| $469M | 0.09% |
5,782,650
-1,617,645
| -22% | -$132M |
|
245
Flowserve
FLS
$10.3B
| $464M | 0.09% |
9,623,642
-3,846,829
| -29% | -$183M |
|
246
Bath & Body Works
BBWI
$3.65B
| $464M | 0.09% |
8,104,347
-405,752
| -5% | -$23.9M |
|
247
Intel
INTC
$509B
| $451M | 0.09% |
11,959,947
-177,396
| -1% | -$6.28M |
|
248
Rayonier
RYN
$6.47B
| $450M | 0.09% |
18,673,544
+92,487
| +0.5% | +$2.26M |
|
249
Middleby
MIDD
$5.38B
| $444M | 0.09% |
3,593,354
+4,264
| +0.1% | +$524K |
|
|
WUBA
250
DELISTED
58.com Inc
WUBA
| $440M | 0.09% |
9,226,786
+445,575
| +5% | +$21.8M |
|
Similar funds
T. Rowe Price Associates's Q3 2016 Portfolio in Review
As of Q3 2016, T. Rowe Price Associates held 2,648 positions worth $498B, up 5.4% from $472B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
T. Rowe Price Associates's Q3 2016 filing shows 135 new, 1,180 increased, 817 reduced and 125 closed positions. Its largest new stake was Fortive: 55,770,886 shares worth $1.79B. The largest sale was TotalEnergies, an estimated $8.15B.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 20% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q3 2016 buy was Fortive: 55,770,886 shares worth $1.79B.
- T. Rowe Price Associates added most to PayPal in Q3 2016, an estimated $1.64B increase.
- T. Rowe Price Associates's biggest Q3 2016 reduction was TotalEnergies, cutting an estimated $8.15B.
- T. Rowe Price Associates fully exited TYCO INTL PLC COM SHS (IRL) in Q3 2016, selling an estimated $1.77B.
- T. Rowe Price Associates's ten largest holdings make up 17% of its $498B portfolio in Q3 2016.
- T. Rowe Price Associates opened 135 new positions and closed 125 in Q3 2016.
- T. Rowe Price Associates's portfolio value rose 5.4% quarter-over-quarter to $498B.
Based on T. Rowe Price Associates's 13F filing for Q3 2016, filed 14 Nov 2016.